Detalhe da pesquisa
1.
A Review of Meaningful Change Thresholds for EORTC QLQ-C30 and FACT-G Within Oncology.
Value Health
; 27(4): 458-468, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191023
2.
International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Cancer
; 129(17): 2727-2740, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37204189
3.
Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials.
Value Health
; 26(10): 1543-1548, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37422075
4.
Healthcare resource utilization of maribavir versus investigator-assigned therapy in transplant recipients with cytomegalovirus infection refractory (with or without genotypic resistance) to prior treatment: Exploratory analysis of the Phase 3 SOLSTICE trial.
Transpl Infect Dis
; 25(3): e14064, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154528
5.
How scoring limits the usability of minimal important differences (MIDs) as responder definition (RD): an exemplary demonstration using EORTC QLQ-C30 subscales.
Qual Life Res
; 32(5): 1247-1253, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35809136
6.
How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold.
Qual Life Res
; 32(5): 1255-1264, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36401757
7.
International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia.
Br J Haematol
; 197(4): 431-441, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35255152
8.
Validity of a single-item indicator of treatment side effect bother in a diverse sample of cancer patients.
Support Care Cancer
; 30(4): 3613-3623, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031830
9.
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials.
BMC Cancer
; 21(1): 1083, 2021 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34620124
10.
A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions.
Value Health
; 24(11): 1651-1659, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711366
11.
Health-related quality of life in pediatric patients with partial onset seizures or primary generalized tonic-clonic seizures receiving adjunctive perampanel.
Epilepsy Behav
; 118: 107938, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33839450
12.
Reliability, validity and important difference estimates for the NCCN-FACT Ovarian Symptom Index-18 (NFOSI-18).
Future Oncol
; 17(30): 3951-3964, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34287020
13.
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.
Lancet Oncol
; 21(2): e83-e96, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007209
14.
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer.
Gynecol Oncol
; 159(2): 515-521, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32972782
15.
Estimation of minimally important differences and responder definitions for EORTC QLQ-MY20 scores in multiple myeloma patients.
Eur J Haematol
; 103(5): 500-509, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31444815
16.
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.
Lancet Oncol
; 19(9): e459-e469, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30191850
17.
Correction: How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold.
Qual Life Res
; 32(5): 1265, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759380
18.
International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
Qual Life Res
; 27(2): 333-345, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29127596
19.
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.
Clin Trials
; 15(6): 624-630, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30141714
20.
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Lancet Oncol
; 18(8): 1104-1115, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28651929